pectenotoxin-2 and Carcinoma

Although pectenotoxin-2 (PTX-2) is known to regulate the actin depolymerization and to induce apoptosis through downregulation of telomerase activity, little is known on its effect on the cell cycle regulation. Therefore, we investigated the effects of PTX-2 on G2/M arrest in human breast cancer cells (MDA-MB-231 and MCF-7). Treatment with PTX-2 significantly suppressed cell proliferation and induced G2/M phase arrest through down-regulation of cyclin B1 and cdc2 expression, but also through phosphorylation of cdc25C. We found increased phosphorylation of ATM and Chk1/2 in a PTX-2 dose-dependent manner. Furthermore, treatment with PTX-2 increased H2O2 generation with correlated G2/M arrest. Our results showed that ATM- and Chk1/2-mediated phosphorylation of cdc25C plays a major role in G2/M arrest, but not in H2O2 generation induced by PTX-2 treatment. We also observed that PTX-2-induced cell cycle arrest was not restricted to p53 status in human breast cancer cells.

Topics: Antineoplastic Agents; Ataxia Telangiectasia Mutated Proteins; Breast Neoplasms; Carcinoma; cdc25 Phosphatases; Cell Cycle; Cell Cycle Proteins; Cell Division; Checkpoint Kinase 1; Checkpoint Kinase 2; DNA-Binding Proteins; Drug Evaluation, Preclinical; Female; Furans; G2 Phase; Humans; Macrolides; Phosphorylation; Protein Kinases; Protein Serine-Threonine Kinases; Pyrans; Tumor Cells, Cultured; Tumor Suppressor Proteins; Up-Regulation